ClinConnect ClinConnect Logo
Search / Trial NCT06730321

Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)

Launched by SHANGHAI 6TH PEOPLE'S HOSPITAL · Dec 9, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Robotic Thyroidectomy Surgical Competency Robotic Thyroidectomy Assessment Score

ClinConnect Summary

This clinical trial is focused on improving surgical techniques for patients undergoing robotic thyroid surgery, which is a minimally invasive method for treating thyroid conditions like cancer and nodules. The researchers are developing a new tool called the Robotic Thyroidectomy Assessment Score (RTAS) to measure how well surgeons perform these complex procedures. The goal is to ensure that surgeries are done safely and effectively, leading to better outcomes for patients.

To participate in this trial, patients should have a diagnosis of differentiated thyroid cancer (not larger than 4 cm) or benign thyroid nodules (not larger than 6 cm) and should have high expectations for cosmetic results after surgery. Importantly, participants should not have had previous neck surgeries or radiation treatment, and their condition should not suggest that the cancer has spread beyond the thyroid. Those who qualify will undergo robotic thyroid surgery and have their surgical performance evaluated using the new scoring tool. This study aims to refine surgical skills and improve the overall patient experience.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Clinical diagnosis of differentiated thyroid cancer with a maximum diameter not exceeding 4 cm
  • Clinical diagnosis of benign thyroid nodules with a maximum diameter not exceeding 6 cm
  • Participants with high cosmetic expectations
  • Participants underwent robotic thyroidectomy without open conversion
  • Exclusion Criteria:
  • Participants with history of neck surgery or radiation
  • Participants with vocal fold fixation by preoperative fibrolaryngoscope
  • Participants with preoperative examination suggestive of distant invasion
  • Participants with fusion or fixed of lymph nodes in the neck

About Shanghai 6th People's Hospital

Shanghai 6th People's Hospital is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital focuses on a wide range of therapeutic areas, striving to enhance patient outcomes and contribute to medical knowledge. With a dedicated team of experienced researchers and clinicians, Shanghai 6th People's Hospital emphasizes rigorous scientific methodology and ethical standards, ensuring that all trials are conducted with the utmost integrity and patient safety in mind. Through collaboration with various stakeholders, the hospital aims to bridge the gap between clinical research and real-world application, ultimately improving healthcare delivery both locally and globally.

Locations

Shanghai, , China

Shanghai, Shanghai, China

Patients applied

0 patients applied

Trial Officials

Ling Zhan, Doctor

Principal Investigator

Shanghai 6th People's Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported